Spacelabs Healthcare receives FDA 510(k) clearance for Arkon anesthesia delivery system

Spacelabs Healthcare has received clearance under Section 510(k) from the U.S. Food and Drug Administration to market Arkon^TM, a high-performance anesthesia delivery system designed from the anesthesiologist's perspective.

Simply put, Arkon is a game changer - the result of anesthesiologist input from across the globe, as well as observation of practice to get it right. Arkon puts patients front and center - by offering anesthesiologists the maximum in functionality, comfort and control - through a combination of innovative technology and ergonomics not previously available in the perioperative environment.

"As an organization, we realize that by enhancing the experience of the anesthesiologist we can also enhance the experience of the patient. Arkon is the result of our passion for focusing on every detail, so that the anesthesiologist can focus on the patient. As a result, we feel confident that Arkon will become the anesthesia delivery system of choice," said Nicholas Ong, President of Spacelabs Healthcare.